Progyny, Inc. reported a notable increase in financial performance for the third quarter of 2025, with total revenue reaching $313.3 million, a 9% rise from $286.6 million in the same period last year. For the nine months ending September 30, 2025, revenue totaled $970.3 million, marking a 12% increase compared to $868.8 million for the same period in 2024. The growth was primarily driven by a 13% increase in revenue from the fertility benefits solution and a 3% increase from the pharmacy benefits solution, attributed to a rise in the number of clients and covered lives.
The company's gross profit for the third quarter was $72.8 million, up 23% from $59.2 million in the prior year, resulting in a gross margin of 23.2%, an increase of 250 basis points. Operating expenses also rose, with sales and marketing expenses increasing by 9% to $17.9 million and general and administrative expenses rising by 10% to $33.4 million. Despite these increases, income from operations improved significantly to $21.5 million, compared to $12.5 million in the previous year, while net income for the quarter was $13.9 million, up from $10.4 million.
Progyny's operational metrics indicate a strong client base, with over 550 employers now utilizing its services, covering approximately 6.7 million lives. The company has maintained a high member satisfaction rate, evidenced by a Net Promoter Score of +79 for its fertility benefits and +84 for its pharmacy benefits solution. The company also reported an increase in assisted reproductive treatment cycles, reflecting higher utilization rates among its members.
Strategically, Progyny completed the acquisition of Benefit Bump LLC in January 2025, enhancing its offerings in parental leave benefits. The company also entered into a revolving credit facility in July 2025, providing up to $200 million to support its operations and growth initiatives. Looking ahead, Progyny anticipates continued growth driven by its expanding client base and the increasing adoption of its fertility and pharmacy benefits solutions, while remaining vigilant to market conditions and competitive pressures.
About Progyny, Inc.
Progyny, Inc. is a benefits management company specializing in fertility, family building, and women’s health solutions in the U.S. It offers comprehensive, data-driven programs including treatment bundles, high-quality specialist networks, personalized support, and integrated pharmacy services. Its services target large employers, aiming to improve clinical outcomes, reduce costs, and attract talent through innovative, accessible fertility benefits.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.